National Institute for Health and Clinical Excellence: Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Technology Assessment Report commissioned by the HTA Programme on behalf of The National Institute for Health and Clinical Excellence

Yaser Adi; Dechao Wang; Susan Jowett; Emma Frew; Edward Day; Susan Bayliss; Tracy Roberts; Amanda Burls

National Institute for Health and Clinical Excellence: Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Technology Assessment Report commissioned by the HTA Programme on behalf of The National Institute for Health and Clinical Excellence

Yaser Adi
, Dechao Wang
, Susan Jowett
, Emma Frew
, Edward Day
, Susan Bayliss
, Tracy Roberts
, Amanda Burls

Health Economics Unit

Research output: Other contribution

Original language	English
Type	Other Contribution
Publication status	Published - 1 Jan 2006

Cite this

Adi, Y., Wang, D., Jowett, S., Frew, E., Day, E., Bayliss, S., Roberts, T., & Burls, A. (2006, Jan 1). National Institute for Health and Clinical Excellence: Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Technology Assessment Report commissioned by the HTA Programme on behalf of The National Institute for Health and Clinical Excellence.

Adi, Yaser ; Wang, Dechao ; Jowett, Susan et al. / National Institute for Health and Clinical Excellence : Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Technology Assessment Report commissioned by the HTA Programme on behalf of The National Institute for Health and Clinical Excellence. 2006.

@misc{d1061ffc2f4c46dea6d7ba672f25ec10,

title = "National Institute for Health and Clinical Excellence: Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Technology Assessment Report commissioned by the HTA Programme on behalf of The National Institute for Health and Clinical Excellence",

author = "Yaser Adi and Dechao Wang and Susan Jowett and Emma Frew and Edward Day and Susan Bayliss and Tracy Roberts and Amanda Burls",

year = "2006",

month = jan,

day = "1",

language = "English",

type = "Other",

}

Adi, Y, Wang, D, Jowett, S , Frew, E , Day, E, Bayliss, S, Roberts, T & Burls, A 2006, National Institute for Health and Clinical Excellence: Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Technology Assessment Report commissioned by the HTA Programme on behalf of The National Institute for Health and Clinical Excellence.

National Institute for Health and Clinical Excellence: Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Technology Assessment Report commissioned by the HTA Programme on behalf of The National Institute for Health and Clinical Excellence. / Adi, Yaser; Wang, Dechao; Jowett, Susan et al.
2006, Other Contribution.

Research output: Other contribution

TY - GEN

T1 - National Institute for Health and Clinical Excellence

T2 - Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Technology Assessment Report commissioned by the HTA Programme on behalf of The National Institute for Health and Clinical Excellence

AU - Adi, Yaser

AU - Wang, Dechao

AU - Jowett, Susan

AU - Frew, Emma

AU - Day, Edward

AU - Bayliss, Susan

AU - Roberts, Tracy

AU - Burls, Amanda

PY - 2006/1/1

Y1 - 2006/1/1

M3 - Other contribution

ER -

Adi Y, Wang D, Jowett S , Frew E , Day E, Bayliss S et al. National Institute for Health and Clinical Excellence: Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Technology Assessment Report commissioned by the HTA Programme on behalf of The National Institute for Health and Clinical Excellence. 2006.